Search Results - "Tat, Vivian"
-
1
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection
Published in PLoS pathogens (01-06-2024)“…COVID-associated coagulopathy seemly plays a key role in post-acute sequelae of SARS- CoV-2 infection. However, the underlying pathophysiological mechanisms…”
Get full text
Journal Article -
2
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
Published in mBio (30-08-2022)“…The U.S. Food and Drug Administration-authorized mRNA- and adenovirus-based SARS-CoV-2 vaccines are intramuscularly injected in two doses and effective in…”
Get full text
Journal Article -
3
Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
Published in Pathogens (Basel) (26-06-2024)“…Coronavirus disease 2019 (COVID-19) continues to cause morbidity and mortality worldwide; therefore, effective treatments remain crucial to controlling it. As…”
Get full text
Journal Article -
4
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Published in Frontiers in immunology (09-03-2023)“…Licensed COVID-19 vaccines ameliorate viral infection by inducing production of neutralizing antibodies that bind the SARS-CoV-2 Spike protein and inhibit…”
Get full text
Journal Article -
5
Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents
Published in Frontiers in chemistry (04-07-2022)“…Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease,…”
Get full text
Journal Article -
6
Endogenous Type I interferon signaling plays a pivotal role in restricted SARS-CoV-2 infection in human ACE2 transgenic mice
Published in The Journal of immunology (1950) (01-05-2021)“…Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become pandemic, resulting in severe…”
Get full text
Journal Article -
7
Induction of multivalent and balanced T cell responses by modular nanoshell vaccine technology
Published in The Journal of immunology (1950) (01-05-2023)“…Abstract After the outbreak of COVID-19, cellular immunity has been shown to provide protection especially in breakthrough infection and B cell-deficient…”
Get full text
Journal Article -
8
Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV‑2 Infection In Vitro and in Vivo
Published in Journal of medicinal chemistry (28-12-2023)“…Enduring occurrence of severe COVID-19 for unvaccinated, aged, or immunocompromised individuals remains an urgent need. Soluble human angiotensin-converting…”
Get full text
Journal Article -
9
Efficacy and self-similarity of SARS-CoV-2 thermal decontamination
Published in Journal of hazardous materials (05-05-2022)“…Dry heat decontamination has been shown to effectively inactivate viruses without compromising the integrity of delicate personal protective equipment (PPE),…”
Get full text
Journal Article -
10
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV‑2 Infection of Human and Monkey Cells
Published in ACS chemical biology (16-04-2021)“…Host-cell cysteine proteases play an essential role in the processing of the viral spike protein of SARS coronaviruses. K777, an irreversible, covalent…”
Get full text
Journal Article -
11
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Published in Science translational medicine (13-03-2024)“…Inhibitors of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M ) such as nirmatrelvir (NTV) and ensitrelvir (ETV) have proven…”
Get more information
Journal Article -
12
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection
Published in Mammalian genome (01-06-2024)“…The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) remains a public health concern and a subject of active research effort. Development of…”
Get full text
Journal Article -
13
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
Published in The Lancet infectious diseases (01-11-2022)“…The global burden of lower respiratory infections (LRIs) and corresponding risk factors in children older than 5 years and adults has not been studied as…”
Get full text
Journal Article -
14
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
Published in The Lancet global health (01-03-2023)“…The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led…”
Get full text
Journal Article